ANDY LA ROCQUE: 'Nobody Knows' When The Long-Awaited New KING DIAMOND Album 'Saint Lucifer's Hospital 1920' Will Arrive

Why It Matters

The update confirms King Diamond’s continued commitment to a multi‑album horror trilogy, keeping fan anticipation high and signaling potential market momentum for new classic‑metal releases. Delays also highlight the logistical and creative challenges of producing organic‑sound records in today’s heavily processed industry.

Key Takeaways

• Album title changed from "The Institute" to "Saint Lucifer's Hospital 1920"
• Only three of La Rocque's eight demo songs selected for album
• Band aims for organic, 80s‑style production, minimal studio tweaking
• European 2025 tour featured ~30 shows across U.K., Greece, Turkey, Finland
• New tracks "Spider Lilly" and "Electro Therapy" already performed live

Pulse Analysis

King Diamond’s upcoming horror trilogy has become a focal point for metal enthusiasts, but the timeline remains fluid. Andy La Rocque’s recent interviews reveal that the first installment, now titled “Saint Lucifer’s Hospital 1920,” is still in the demo‑to‑recording phase. While La Rocque sent eight song ideas to frontman King Diamond, only three have been approved, and the vocalist still needs to complete five to six additional tracks. This selective approach reflects a strategic emphasis on quality over speed, a tactic that resonates with fans who value the band’s legacy of theatrical storytelling and intricate compositions.

The production philosophy marks a departure from the hyper‑polished sound common in modern metal. La Rocque emphasizes an “organic” feel, mirroring the band’s 1980s roots with live‑room drum ambience and fewer digital tweaks. By retaining raw guitar tones and allowing slight imperfections, King Diamond aims to deliver an authentic listening experience that differentiates the album in a market saturated with over‑processed releases. This approach may also reduce studio costs, a notable consideration after the band cited rising expenses on its 2024 U.S. tour.

Touring dynamics further illustrate the band’s evolving stability. After a challenging U.S. leg, the 2025 European circuit—spanning roughly 30 dates across the U.K., Greece, Turkey and Finland—demonstrated tighter logistics and a cohesive lineup. Live testing of new songs like “Spider Lilly” and “Electro Therapy” has generated buzz and provided real‑world feedback that could shape final arrangements. As King Diamond prepares to film a video for the upcoming single “Lobotomy,” the combination of organic production, strategic song selection, and renewed touring momentum positions the album to make a notable impact on the heavy‑metal landscape.